CHINA PHARMA HOLDINGS, INC.
CPHIDrugs in Pipeline
13
Phase 3 Programs
9
Upcoming Catalysts
1
Next Catalyst
Aug 15, 2026
22wMarket Overview
Stock performance and key metrics
1 upcoming, 1 past
Investigational live attenuated varicella vaccine
Varicella
OxyNorm Capsules
Postoperative Pain
5% Lidocaine patch
Herpes Zoster Pain
Oxycodone/naloxone prolonged release tablets
Non Cancer Pain
Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula polymorpha)
Norovirus Infections
Oxycodone
Other Acute Postoperative Pain
Fezolinetant
Hot Flashes
Romiplostim
Immune Thrombocytopenia
pralatrexate
Refractory Peripheral T-Cell Lymphoma
Yttrium [90Y] Microsphere Injection
HCC
Biological/Vaccine: 11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha)
HPV Infection
ASC30 tablets
T2DM (Type 2 Diabetes Mellitus)
IAP0971
Advanced Malignant Tumors
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Investigational live attenuated varicella vaccine | Phase 3 | Varicella | - | - |
OxyNorm Capsules | Phase 3 | Postoperative Pain | - | - |
5% Lidocaine patch | Phase 3 | Herpes Zoster Pain | - | - |
Oxycodone/naloxone prolonged release tablets | Phase 3 | Non Cancer Pain | - | - |
Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula polymorpha) | Phase 3 | Norovirus Infections | - | - |
Oxycodone | Phase 3 | Other Acute Postoperative Pain | - | - |
Fezolinetant | Phase 3 | Hot Flashes | - | - |
Romiplostim | Phase 3 | Immune Thrombocytopenia | - | - |
pralatrexate | Phase 3 | Refractory Peripheral T-Cell Lymphoma | - | - |
Yttrium [90Y] Microsphere Injection | Phase 2 | HCC | - | - |
Biological/Vaccine: 11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha) | Phase 2 | HPV Infection | - | - |
ASC30 tablets | Phase 2 | T2DM (Type 2 Diabetes Mellitus) | - | - |
IAP0971 | Phase 2 | Advanced Malignant Tumors | - | - |